Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Senti Biosciences (SNTI) Leases (2021 - 2025)

Senti Biosciences has reported Leases over the past 5 years, most recently at $11.5 million for Q4 2025.

  • Quarterly results put Leases at $11.5 million for Q4 2025, down 17.44% from a year ago — trailing twelve months through Dec 2025 was $11.5 million (down 17.44% YoY), and the annual figure for FY2025 was $11.5 million, down 17.44%.
  • Leases for Q4 2025 was $11.5 million at Senti Biosciences, down from $12.3 million in the prior quarter.
  • Over the last five years, Leases for SNTI hit a ceiling of $20.7 million in Q4 2021 and a floor of $11.5 million in Q4 2025.
  • Median Leases over the past 5 years was $16.0 million (2023), compared with a mean of $16.0 million.
  • Biggest five-year swings in Leases: fell 9.88% in 2023 and later dropped 17.44% in 2025.
  • Senti Biosciences' Leases stood at $20.7 million in 2021, then dropped by 11.06% to $18.4 million in 2022, then dropped by 11.64% to $16.3 million in 2023, then fell by 14.29% to $13.9 million in 2024, then dropped by 17.44% to $11.5 million in 2025.
  • The last three reported values for Leases were $11.5 million (Q4 2025), $12.3 million (Q3 2025), and $12.8 million (Q2 2025) per Business Quant data.